Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Jul;78(1):205–213. doi: 10.1172/JCI112553

The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. Mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts.

B A Amendt, W J Rhead
PMCID: PMC329551  PMID: 3722376

Abstract

The multiple acyl-coenzyme A (CoA) dehydrogenation disorders (MAD) include severe (S) and mild (M) variants, glutaric aciduria type II (MAD:S) and ethylmalonic-adipic aciduria (MAD:M). Intact MAD:M mitochondria oxidized [1-14C]octanoate, [1-14C]palmityl-CoA, and [1,5-14C]glutarate at 20-46% of control levels; MAD:S mitochondria oxidized these three substrates at 0.4-18% of control levels. In MAD:M mitochondria, acyl-CoA dehydrogenase (ADH) activities were similar to control, whereas MAD:S ADH activities ranged from 38% to 73% of control. Electron transfer flavoprotein (ETF) activities in five MAD:M cell lines ranged from 29 to 51% of control (P less than 0.01); ETF deficiency was the primary enzymatic defect in two MAD:M lines. In four MAD:S patients, ETF activities ranged from 3% to 6% of control (P less than 0.001); flavin adenine dinucleotide addition increased residual ETF activity from 4% to 21% of control in a single MAD:S line (P less than 0.01). Three MAD:S patients had ETF activities ranging from 33 to 53% of control; other investigators found deficient ETF-dehydrogenase activity in these MAD:S and three of our MAD:M cell lines.

Full text

PDF
205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amendt B. A., Rhead W. J. Catalytic defect of medium-chain acyl-coenzyme A dehydrogenase deficiency. Lack of both cofactor responsiveness and biochemical heterogeneity in eight patients. J Clin Invest. 1985 Sep;76(3):963–969. doi: 10.1172/JCI112096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beckmann J. D., Frerman F. E. Electron-transfer flavoprotein-ubiquinone oxidoreductase from pig liver: purification and molecular, redox, and catalytic properties. Biochemistry. 1985 Jul 16;24(15):3913–3921. doi: 10.1021/bi00336a016. [DOI] [PubMed] [Google Scholar]
  3. Beckmann J. D., Frerman F. E., McKean M. C. Inhibition of general acyl CoA dehydrogenase by electron transfer flavoprotein semiquinone. Biochem Biophys Res Commun. 1981 Oct 30;102(4):1290–1294. doi: 10.1016/s0006-291x(81)80151-9. [DOI] [PubMed] [Google Scholar]
  4. Beckmann J. D., Frerman F. E. Reaction of electron-transfer flavoprotein with electron-transfer flavoprotein-ubiquinone oxidoreductase. Biochemistry. 1985 Jul 16;24(15):3922–3925. doi: 10.1021/bi00336a017. [DOI] [PubMed] [Google Scholar]
  5. Bennett M. J., Curnock D. A., Engel P. C., Shaw L., Gray R. G., Hull D., Patrick A. D., Pollitt R. J. Glutaric aciduria type II: biochemical investigation and treatment of a child diagnosed prenatally. J Inherit Metab Dis. 1984;7(2):57–61. doi: 10.1007/BF01805802. [DOI] [PubMed] [Google Scholar]
  6. Böhm N., Uy J., Kiessling M., Lehnert W. Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two newborn brothers. II. Morphology and pathogenesis. Eur J Pediatr. 1982 Sep;139(1):60–65. doi: 10.1007/BF00442082. [DOI] [PubMed] [Google Scholar]
  7. Christensen E. Glutaryl-CoA dehydrogenase activity determined with intact electron-transport chain: application to glutaric aciduria type II. J Inherit Metab Dis. 1984;7 (Suppl 2):103–104. doi: 10.1007/978-94-009-5612-4_26. [DOI] [PubMed] [Google Scholar]
  8. Christensen E., Kølvraa S., Gregersen N. Glutaric aciduria type II: evidence for a defect related to the electron transfer flavoprotein or its dehydrogenase. Pediatr Res. 1984 Jul;18(7):663–667. doi: 10.1203/00006450-198407000-00020. [DOI] [PubMed] [Google Scholar]
  9. Coude F. X., Ogier H., Charpentier C., Thomassin G., Checoury A., Amedee-Manesme O., Saudubray J. M., Frezal J. Neonatal glutaric aciduria type II: an X-linked recessive inherited disorder. Hum Genet. 1981;59(3):263–265. doi: 10.1007/BF00283677. [DOI] [PubMed] [Google Scholar]
  10. Davidson B., Schulz H. Separation, properties, and regulation of acyl coenzyme A dehydrogenases from bovine heat and liver. Arch Biochem Biophys. 1982 Jan;213(1):155–162. doi: 10.1016/0003-9861(82)90450-7. [DOI] [PubMed] [Google Scholar]
  11. Duran M., Walther F. J., Bruinvis L., Wadman S. K. The urinary excretion of ethylmalonic acid: what level requires further attention? Biochem Med. 1983 Apr;29(2):171–175. doi: 10.1016/0006-2944(83)90037-6. [DOI] [PubMed] [Google Scholar]
  12. Dusheiko G., Kew M. C., Joffe B. I., Lewin J. R., Mantagos S., Tanaka K. Recurrent hypoglycemia associated with glutaric aciduria type II in an adult. N Engl J Med. 1979 Dec 27;301(26):1405–1409. doi: 10.1056/NEJM197912273012601. [DOI] [PubMed] [Google Scholar]
  13. Frerman F. E., Goodman S. I. Deficiency of electron transfer flavoprotein or electron transfer flavoprotein:ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4517–4520. doi: 10.1073/pnas.82.13.4517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Furuta S., Miyazawa S., Hashimoto T. Induction of acyl-CoA dehydrogenases and electron transfer flavoprotein and their roles in fatty acid oxidation in rat liver mitochondria. J Biochem. 1981 Dec;90(6):1751–1756. doi: 10.1093/oxfordjournals.jbchem.a133652. [DOI] [PubMed] [Google Scholar]
  15. Furuta S., Miyazawa S., Hashimoto T. Purification and properties of rat liver acyl-CoA dehydrogenases and electron transfer flavoprotein. J Biochem. 1981 Dec;90(6):1739–1750. doi: 10.1093/oxfordjournals.jbchem.a133651. [DOI] [PubMed] [Google Scholar]
  16. Goodman S. I., Frerman F. E. Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency). J Inherit Metab Dis. 1984;7 (Suppl 1):33–37. doi: 10.1007/BF03047371. [DOI] [PubMed] [Google Scholar]
  17. Goodman S. I., McCabe E. R., Fennessey P. V., Mace J. W. Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II) with transient hypersarcosinemia and sarcosinuria; possible inherited deficiency of an electron transfer flavoprotein. Pediatr Res. 1980 Jan;14(1):12–17. doi: 10.1203/00006450-198001000-00004. [DOI] [PubMed] [Google Scholar]
  18. Goodman S. I., Stene D. O., McCabe E. R., Norenberg M. D., Shikes R. H., Stumpf D. A., Blackburn G. K. Glutaric acidemia type II: clinical, biochemical, and morphologic considerations. J Pediatr. 1982 Jun;100(6):946–950. doi: 10.1016/s0022-3476(82)80525-8. [DOI] [PubMed] [Google Scholar]
  19. Gorelick R. J., Mizzer J. P., Thorpe C. Purification and properties of electron-transferring flavoprotein from pig kidney. Biochemistry. 1982 Dec 21;21(26):6936–6942. doi: 10.1021/bi00269a049. [DOI] [PubMed] [Google Scholar]
  20. Green A., Marshall T. G., Bennett M. J., Gray R. G., Pollitt R. J. Riboflavin-responsive ethylmalonic-adipic aciduria. J Inherit Metab Dis. 1985;8(2):67–70. doi: 10.1007/BF01801667. [DOI] [PubMed] [Google Scholar]
  21. Gregersen N., Kølvraa S., Rasmussen K., Christensen E., Brandt N. J., Ebbesen F., Hansen F. H. Biochemical studies in a patient with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II. J Inherit Metab Dis. 1980;3(3):67–72. doi: 10.1007/BF02312527. [DOI] [PubMed] [Google Scholar]
  22. Gregersen N. The acyl-CoA dehydrogenation deficiencies. Recent advances in the enzymic characterization and understanding of the metabolic and pathophysiological disturbances in patients with acyl-CoA dehydrogenation deficiencies. Scand J Clin Lab Invest Suppl. 1985;174:1–60. [PubMed] [Google Scholar]
  23. Gregersen N., Wintzensen H., Christensen S. K., Christensen M. F., Brandt N. J., Rasmussen K. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. Pediatr Res. 1982 Oct;16(10):861–868. doi: 10.1203/00006450-198210000-00012. [DOI] [PubMed] [Google Scholar]
  24. Hall C. L., Kamin H. The purification and some properties of electron transfer flavoprotein and general fatty acyl coenzyme A dehydrogenase from pig liver mitochondria. J Biol Chem. 1975 May 10;250(9):3476–3486. [PubMed] [Google Scholar]
  25. Harpey J. P., Charpentier C., Goodman S. I., Darbois Y., Lefèbvre G., Sebbah J. Multiple acyl-CoA dehydrogenase deficiency occurring in pregnancy and caused by a defect in riboflavin metabolism in the mother. Study of a kindred with seven deaths in infancy: Value of riboflavin therapy in preventing this syndrome. J Pediatr. 1983 Sep;103(3):394–398. doi: 10.1016/s0022-3476(83)80410-7. [DOI] [PubMed] [Google Scholar]
  26. Ikeda Y., Dabrowski C., Tanaka K. Separation and properties of five distinct acyl-CoA dehydrogenases from rat liver mitochondria. Identification of a new 2-methyl branched chain acyl-CoA dehydrogenase. J Biol Chem. 1983 Jan 25;258(2):1066–1076. [PubMed] [Google Scholar]
  27. Ikeda Y., Tanaka K. Purification and characterization of 2-methyl-branched chain acyl coenzyme A dehydrogenase, an enzyme involved in the isoleucine and valine metabolism, from rat liver mitochondria. J Biol Chem. 1983 Aug 10;258(15):9477–9487. [PubMed] [Google Scholar]
  28. Ikeda Y., Tanaka K. Purification and characterization of isovaleryl coenzyme A dehydrogenase from rat liver mitochondria. J Biol Chem. 1983 Jan 25;258(2):1077–1085. [PubMed] [Google Scholar]
  29. Lehnert W., Wendel U., Lindenmaier S., Böhm N. Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers. I. Clinical, metabolical, and biochemical findings. Eur J Pediatr. 1982 Sep;139(1):56–59. doi: 10.1007/BF00442081. [DOI] [PubMed] [Google Scholar]
  30. Mantagos S., Genel M., Tanaka K. Ethylmalonic-adipic aciduria. In vivo and in vitro studies indicating deficiency of activities of multiple acyl-CoA dehydrogenases. J Clin Invest. 1979 Dec;64(6):1580–1589. doi: 10.1172/JCI109619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Matsui S. M., Mahoney M. J., Rosenberg L. E. The natural history of the inherited methylmalonic acidemias. N Engl J Med. 1983 Apr 14;308(15):857–861. doi: 10.1056/NEJM198304143081501. [DOI] [PubMed] [Google Scholar]
  32. Mitchell G., Saudubray J. M., Gubler M. C., Habib R., Ogier H., Frezal J., Boue J. Congenital anomalies in glutaric aciduria type 2. J Pediatr. 1984 Jun;104(6):961–962. doi: 10.1016/s0022-3476(84)80520-x. [DOI] [PubMed] [Google Scholar]
  33. Mooy P. D., Przyrembel H., Giesberts M. A., Scholte H. R., Blom W., van Gelderen H. H. Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin. Eur J Pediatr. 1984 Dec;143(2):92–95. doi: 10.1007/BF00445792. [DOI] [PubMed] [Google Scholar]
  34. Niederwieser A., Steinmann B., Exner U., Neuheiser F., Redweik U., Wang M., Rampini S., Wendel U. Multiple acyl-Co A dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide. Helv Paediatr Acta. 1983 Mar;38(1):9–26. [PubMed] [Google Scholar]
  35. Okamura-Ikeda K., Ikeda Y., Tanaka K. An essential cysteine residue located in the vicinity of the FAD-binding site in short-chain, medium-chain, and long-chain acyl-CoA dehydrogenases from rat liver mitochondria. J Biol Chem. 1985 Jan 25;260(2):1338–1345. [PubMed] [Google Scholar]
  36. Przyrembel H., Wendel U., Becker K., Bremer H. J., Bruinvis L., Ketting D., Wadman S. K. Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta. 1976 Jan 16;66(2):227–239. doi: 10.1016/0009-8981(76)90060-7. [DOI] [PubMed] [Google Scholar]
  37. Rhead W. J., Amendt B. A. Electron-transferring flavoprotein deficiency in the multiple acyl-CoA dehydrogenation disorders, glutaric aciduria type II and ethylmalonic--adipic aciduria. J Inherit Metab Dis. 1984;7 (Suppl 2):99–100. doi: 10.1007/978-94-009-5612-4_24. [DOI] [PubMed] [Google Scholar]
  38. Rhead W. J., Amendt B. A., Fritchman K. S., Felts S. J. Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts. Science. 1983 Jul 1;221(4605):73–75. doi: 10.1126/science.6857268. [DOI] [PubMed] [Google Scholar]
  39. Rhead W. J., Hall C. L., Tanaka K. Novel tritium release assays for isovaleryl-CoA and butyryl-CoA dehydrogenases. J Biol Chem. 1981 Feb 25;256(4):1616–1624. [PubMed] [Google Scholar]
  40. Rhead W. J., Tanaka K. Demonstration of a specific mitochondrial isovaleryl-CoA dehydrogenase deficiency in fibroblasts from patients with isovaleric acidemia. Proc Natl Acad Sci U S A. 1980 Jan;77(1):580–583. doi: 10.1073/pnas.77.1.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Rhead W., Mantagos S., Tanaka K. Glutaric aciduria type II: in vitro studies on substrate oxidation, acyl-CoA dehydrogenases, and electron-transferring flavoprotein in cultured skin fibroblasts. Pediatr Res. 1980 Dec;14(12):1339–1342. doi: 10.1203/00006450-198012000-00013. [DOI] [PubMed] [Google Scholar]
  42. Sakurai T., Miyazawa S., Furuta S., Hashimoto T. Riboflavin deficiency and beta-oxidation systems in rat liver. Lipids. 1982 Sep;17(9):598–604. doi: 10.1007/BF02535365. [DOI] [PubMed] [Google Scholar]
  43. Steenkamp D. J., Husain M. The effect of tetrahydrofolate on the reduction of electron transfer flavoprotein by sarcosine and dimethylglycine dehydrogenases. Biochem J. 1982 Jun 1;203(3):707–715. doi: 10.1042/bj2030707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Stokke O., Goodman S. I., Thompson J. A., Miles B. S. Glutaric aciduria; presence of glutaconic and beta-hydroxyglutaric acids in urine. Biochem Med. 1975 Apr;12(4):386–391. doi: 10.1016/0006-2944(75)90071-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES